Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future Perspectives
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-34521-1_22
Reference114 articles.
1. Dredge, K., Hammond, E., Davis, K., Li, C. P., Liu, L., Johnstone, K., et al. (2010). The PG500 series: Novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy. Investigational New Drugs, 28, 276–283. https://doi.org/10.1007/s10637-009-9245-5 .
2. Hammond, E., Handley, P., Dredge, K., & Bytheway, I. (2013). Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues. FEBS Open Bio, 3, 346–351. https://doi.org/10.1016/j.fob.2013.07.007 .
3. Jung, D.-B., Yun, M., Kim, E.-O., Kim, J., Kim, B., Jung, J. H., et al. (2015). The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine. Oncotarget, 6, 4992–5004. https://doi.org/10.18632/oncotarget.3214 .
4. Winterhoff, B., Freyer, L., Hammond, E., Giri, S., Mondal, S., Roy, D., et al. (2015). PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples. European Journal of Cancer, 51, 879–892. https://doi.org/10.1016/j.ejca.2015.02.007 .
5. Rapraeger, A. C., Krufka, A., & Olwin, B. B. (1991). Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science, 252, 1705–1708. http://www.ncbi.nlm.nih.gov/pubmed/1646484 .
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A New Synthesized Dicarboxylated Oxy-Heparin Efficiently Attenuates Tumor Growth and Metastasis;Cells;2024-01-23
2. Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer;Life Sciences;2023-11
3. Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation;Cell Death & Disease;2023-07-25
4. CD9 co-operation with syndecan-1 is required for a major staphylococcal adhesion pathway;mBio;2023-07-24
5. Potential roles of heparanase in cancer therapy: Current trends and future direction;Journal of Cellular Physiology;2023-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3